Clinical Trials

Boolean Natural Query Expansion

HIFU Lesion Control in Patients With Non-metastatic Progressive Prostate Cancer

High-intensity focused ultrasound focal ablation uses high-energy sound waves to kill tumor cells. This phase II trial is studying the side effects of high-intensity focused ultrasound focal ablation and to see how well it works in treating patients with progressive prostate cancer. Patients undergo focal ablation with high-intensity focused ultrasound (HIFU) ablation on day 1. Treatment may repeat at 6 months in patients with progressive disease. Blood samples and prostate biopsies are collected periodically for further analysis

Start date: 1 Jul 2009
Finish date:
Chief Investigator - Mark Emberton, UCLH
[Complete article]

Mon, 1st Jun, 2020